will insurance cover glp-1 for high cholesterol Medicaid Coverage of and Spending on GLP-1s Perspectives from employers on the
Description
One patient Dana has helped was experiencing noticeable volume loss through the mid-face

Nausea rates in retatrutide trials reached approximately 45% at the maximum dose, compared to roughly 31% for tirzepatide

In the T2D trial, WL was lower than in the obesity trial however the trial duration was shorter (36 weeks) [46]

Lau D, Gamble JM

Other GLP-1 receptor agonist products are used off-label for weight loss
The LEADER cardiovascular outcomes trial demonstrated cardiovascular benefits, and subsequent analyses have shown reductions in inflammatory biomarkers
